Updates on the risk factors for latent tuberculosis reactivation and their managements

JW Ai, QL Ruan, QH Liu, WH Zhang - Emerging microbes & …, 2016 - Taylor & Francis
The preventive treatment of latent tuberculosis infection (LTBI) is of great importance for the
elimination and control of tuberculosis (TB) worldwide, but existing screening methods for …

Treatment of latent tuberculosis infection: an updated network meta-analysis

D Zenner, N Beer, RJ Harris, MC Lipman… - Annals of internal …, 2017 - acpjournals.org
Background: Treatment of latent tuberculosis infection (LTBI) is an important component of
tuberculosis (TB) control, and this study updates a previous network meta-analysis of the …

[HTML][HTML] Guidelines for the treatment of latent tuberculosis infection: recommendations from the National Tuberculosis Controllers Association and CDC, 2020

TR Sterling - MMWR. Recommendations and Reports, 2020 - cdc.gov
Comprehensive guidelines for treatment of latent tuberculosis infection (LTBI) among
persons living in the United States were last published in 2000 (American Thoracic Society …

One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis

S Swindells, R Ramchandani, A Gupta… - … England Journal of …, 2019 - Mass Medical Soc
Background Tuberculosis is the leading killer of patients with human immunodeficiency virus
(HIV) infection. Preventive therapy is effective, but current regimens are limited by poor …

Three months of rifapentine and isoniazid for latent tuberculosis infection

TR Sterling, ME Villarino, AS Borisov… - … England Journal of …, 2011 - Mass Medical Soc
Background Treatment of latent Mycobacterium tuberculosis infection is an essential
component of tuberculosis control and elimination. The current standard regimen of …

[PDF][PDF] Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings

World Health Organization - 2011 - apps.who.int
All members of the Guidelines Group were asked to complete a World Health Organization
(WHO) declaration of interest form and only two declared a conflict of interest. These were …

Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis

D Yee, C Valiquette, M Pelletier, I Parisien… - American journal of …, 2003 - atsjournals.org
Major adverse reactions to antituberculosis drugs can cause significant morbidity, and
compromise treatment regimens for tuberculosis (TB). Among patients treated for active TB …

Treatment of latent tuberculosis infection in HIV infected persons

C Akolo, I Adetifa, S Shepperd… - Cochrane database of …, 2010 - cochranelibrary.com
Background Individuals with human immunodeficiency virus (HIV) infection are at an
increased risk of developing active tuberculosis (TB). It is known that treatment of latent TB …

Recommendations for the outpatient surveillance of renal transplant recipients

BL Kasiske, MA Vazquez, WE Harmon… - Journal of the …, 2000 - journals.lww.com
Many complications after renal transplantation can be prevented if they are detected early.
Guidelines have been developed for the prevention of diseases in the general population …

[HTML][HTML] Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano …

A Badje, R Moh, D Gabillard, C Guéhi… - The Lancet global …, 2017 - thelancet.com
Background Temprano ANRS 12136 was a factorial 2× 2 trial that assessed the benefits of
early antiretroviral therapy (ART; ie, in patients who had not reached the CD4 cell count …